4-Methyl-2-(1-pyrrolyl)pyridine

Catalog No.: 
ACTMCF927
CAS No.: 
90996-18-2
Molecular Formula: 
C10H10N2
Molecular Weight: 
158.20
4-Methyl-2-(1-pyrrolyl)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$117.00InquiryInquiry
5g95%$387.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Methyl-2-(1-pyrrolyl)pyridine
IUPAC Name4-methyl-2-(1H-pyrrol-1-yl)pyridine
MDL No.MFCD02665532
Molecular FormulaC10H10N2
Molecular Weight158.20
SMILESCC1=CC(N2C=CC=C2)=NC=C1
InChI KeyIYQKSFDFSHYLNT-UHFFFAOYSA-N
Synonym4-Methyl-2-(1-pyrrolyl)pyridine, 98%;Pyridine, 4-methyl-2-(1H-pyrrol-1-yl)-;4-Methyl-2-(1H-pyrrol-1-yl)pyridine;4-methyl-2-pyrrol-1-ylpyridine
CAS No.90996-18-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACTMCF927 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBETI826 route compound structure diagram
    ACBETI8264926-28-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTMCF927 route product structure diagram
    ACTMCF92790996-18-2
Inquiry

2. ACTMCF927 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTMCF927 route product structure diagram
    ACTMCF92790996-18-2
Inquiry

3. ACTMCF927 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTMCF927 route product structure diagram
    ACTMCF92790996-18-2
Inquiry

Comments (0)